Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group (Q71182389)
Jump to navigation
Jump to search
scientific article published on 01 August 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group |
scientific article published on 01 August 1996 |
Statements
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group (English)
B S Graham
G J Gorse
K Weinhold
M C Keefer
D H Schwartz
T J Matthews
J R Esterlitz
F Sinangil